News Search Results

Displaying Results 26-50 of 147 "insomnia"

Apr 22, 2026, 09:02 ET Sleep Medicine Physician Dr. Funke Afolabi-Brown Launches Online Insomnia Program, Joins HumanUp as Expert Sleep Partner

including a new role as sleep expert for the parenting platform HumanUp, a feature in Sleep Review Magazine, and the launch of a comprehensive online insomnia program for adults. Dr. Afolabi-Brown has been named the sleep expert for HumanUp, a newly launching parenting platform that provides expert-driven

More news about: Restful Sleep MD


Apr 16, 2026, 09:00 ET Glocusent N18 Mini Sound Machine Hits Kickstarter Goal in 14 Days with 117 Backers from 17 Countries

device that combining engineered acoustic frequencies with ambient lighting for multi-sensory relaxation, bringing accessible sleep technology to insomnia sufferers worldwide.

More news about: Glocusent Co., Ltd


Apr 15, 2026, 09:00 ET Insomnia Cookies Gets Baked for 4/20 with Limited-Edition Munchie-Inspired Cookies

www.InsomniaCookies.com.About Insomnia Cookies Insomnia Cookies is a rapidly expanding late-night bakery concept headquartered in Philadelphia, PA. Founded at the University of Pennsylvania by then-student Seth Berkowitz, Insomnia Cookies has been feeding the insatiable hunger

More news about: Insomnia Cookies


Apr 13, 2026, 11:00 ET How Sleep Biomarkers Improve Clinical Development and Clinical Assessment in Depression, Upcoming Webinar Hosted by Xtalks

launch.Many current depression trials measure sleep through patient-reported outcomes such as the Pittsburgh Sleep Quality Index (PSQI) or Insomnia Severity Index (ISI), which can be useful for characterizing patients' perceptions of sleep improvements, but can be uncorrelated with patients' underlying

More news about: Xtalks


Apr 09, 2026, 07:45 ET Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meeting

patients at recommended doses, one patient reported insomnia following abrupt discontinuation of XYWAV. In the XYWAV clinical trial in adult idiopathic hypersomnia patients at recommended doses, six patients reported insomnia, two patients reported early insomnia, and one patient reported visual and auditory

More news about: Jazz Pharmaceuticals plc


Apr 08, 2026, 07:07 ET New Open-Access Patient Library from University of Arizona Andrew Weil Center for Integrative Medicine Brings Whole-Person Health Resources to Clinicians and the Public

practices (4-7-8 breath, breathwork, progressive muscle relaxation), sleep health, and condition-specific resources addressing Type 2 Diabetes and Insomnia.For clinicians, the library functions as a point-of-care tool. Handouts can be searched by keyword, condition, or topic; shared as a direct

More news about: University of Arizona Andrew Weil Center for Integrative Medicine


Apr 07, 2026, 11:00 ET U.S. Department of Veterans Affairs Launches Nation's Largest In-Home VR Mental Health Initiative for Veterans

receiving care through the VA may experience symptoms of PTSDVeterans are more likely to report chronic sleep disturbances, including insomniaAnxiety and hyperarousal can impact everything from daily functioning to medical proceduresYet access to consistent, engaging

More news about: Healium


Apr 06, 2026, 08:04 ET SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting

dying; attempting to commit suicide; new or worse depression, anxiety, or irritability; feeling agitated or restless; panic attacks; trouble sleeping (insomnia); acting aggressive; being angry or violent; acting on dangerous impulses; an extreme increase in activity and talking (mania); or other unusual changes

More news about: SK Life Science, Inc.


Apr 03, 2026, 15:02 ET The Inner Circle acknowledges Daniela T. Rizzo as a 2026 Pinnacle Lifetime Member

commitment to advancing both psychiatric treatment and regenerative health. As a practicing psychiatrist, she specializes in treating adults with ADHD, insomnia, anxiety, and depression, with a particular focus on high achieving individuals who experience non severe presentations of these conditions. Her approach

More news about: The Inner Circle


Apr 02, 2026, 08:00 ET Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression

Symptoms of PPD include hallmarks of major depression, including, but not limited to, sadness, depressed mood, loss of interest, change in appetite, insomnia, sleeping too much, fatigue, difficulty thinking/concentrating, excessive crying, fear of harming the baby/oneself, and/or thoughts of death or suicide.

More news about: Lipocine Inc.


Apr 01, 2026, 05:27 ET American Parkinson Disease Association Kicks Off Awareness Month with Launch of New Public Service Announcement

Elisa Mederos, 77, of Deerfield Beach, Florida, who was diagnosed in 2014. Elisa doesn't let challenges like muscle pain and persistent insomnia stop her from filling her days with new hobbies, including painting and learning to play the piano.Joan Furman, 78,

More news about: American Parkinson Disease Association, Inc.


Apr 01, 2026, 00:01 ET CFOs Emerge as CEOs' Top Threat to Job Security As Internal Pressures Intensify

CEO Insomnia Index, a global study based on a survey of approximately 500 CEOs leading companies with revenues ranging from $100 million to more than $5 billion,

More news about: Boston Consulting Group (BCG)


Mar 27, 2026, 10:45 ET Earplugs Market Size worth USD 2,218.29 Million by 2032, Exclusive Report by Maximize Market Research

Sleep Tech Devices Market by Product Type (Wearables, Smart Beds, Headbands, Rings, Sleep Pads), Application (Insomnia, Sleep Apnea, Circadian Rhythm, Sleep Quality Monitoring) and Region – Global Forecast to 2032

More news about: Maximize Market Research Pvt. Ltd.


Mar 27, 2026, 08:00 ET Otsuka Pharmaceutical to Acquire Transcend Therapeutics

frequently reported treatment‑emergent adverse events included headache, decreased appetite, nausea, dizziness, increased blood pressure, dry mouth, and insomnia. These events were typically transient, occurred on the day of dosing, and resolved within one day.5,2About PTSDPost‑traumatic

More news about: Otsuka Pharmaceutical Co.; Transcend Therapeutics


Mar 27, 2026, 01:03 ET Women-Founded Baloo Living Hits 100,000 Orders with Sustainable Weighted Blankets

blankets use deep pressure stimulation to promote relaxation and improve sleep quality, with growing research suggesting positive effects on anxiety, insomnia, and stress. Baloo Living ships internationally from the US through its website at

More news about: Baloo Living


Mar 25, 2026, 12:01 ET Immune response to cancer may cause brain disease

York Times bestseller Brain on Fire. In ANRE, the immune system attacks proteins in the brain called NMDA receptors, causing psychosis, insomnia, and seizures. Many patients with this condition are found to have a tumor that produces the same NMDA receptors, but outside the brain.Using

More news about: Cold Spring Harbor Laboratory


Mar 18, 2026, 08:38 ET Adverse Drug Events--Estimated Among Leading Causes of Death--Prompt National Policy Discussion on Medication Safety

ago, my family learned the hard way about the dangers of medication-related harm when my husband died after being prescribed an antidepressant for insomnia. Since then, I have dedicated my life to shining a light on harms in medicine and advocating for stronger drug safety."National Adverse Drug

More news about: American Society of Pharmacovigilance


Mar 17, 2026, 10:13 ET NIH-Funded Randomized Clinical Trial Evaluating Weekly BRIXADI® for Opioid Use Disorder in Pregnancy and 12-months Postpartum Published in JAMA Internal Medicine

BRIXADI administration (in ≥5% of patients) were injection site pain, headache, constipation, nausea, injection site erythema, injection site pruritus, insomnia, and urinary tract infection. DRUG INTERACTIONS CYP3A4 Inhibitors and Inducers: Monitor patients starting or ending CYP3A4

More news about: Braeburn


Mar 05, 2026, 15:55 ET Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line

neurologic toxicity in 6%. Neurologic toxicities reported in ≥5% of patients included headache (27%), sensory neuropathy (16%), motor dysfunction (15%), insomnia (12%), encephalopathy (11%), and dizziness (8%). Fatal neurologic toxicity occurred in 0.4% of patients, including Guillain-Barré syndrome and status

More news about: Johnson & Johnson


Mar 03, 2026, 11:16 ET New Research from The Fuchsia Tent Shows Making Midlife Women Visible in Employer Health Data Could Save U.S. Companies $26.6B

any evidence of it in their medical record despite 100% of that population being in some stage of the menopausal transition. Symptoms like anxiety, insomnia, joint pain, and cognitive changes are captured in ICD-10 coding as standalone conditions and never linked to menopause, leading to widespread mis-

More news about: The Fuchsia Tent


Feb 26, 2026, 06:10 ET Three CrossFit Sessions for Cancer Survivors Beginning Soon in Genesee, Oakland and Wayne Counties

outcomes experienced by African American cancer survivors. Both studies reveal that cancer survivors who meet ACS's exercise recommendations report less insomnia and better sleep quality, showing that exercise is a benefit to cancer survivors. The team has previously shown that sleep health is one of the most

More news about: Karmanos Cancer Institute


Feb 24, 2026, 16:01 ET Workday Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results

the company's next chapter.Workday welcomed new customers including Boston Children's Hospital, Copenhagen Airports A/S, Fruit of the Loom, Insomnia Cookies, Lavazza, Sargent & Lundy, State of New York Unified Court System, and Queensland University of Technology, and expanded existing relationships

More news about: Workday Inc.


Feb 18, 2026, 08:00 ET Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)

Symptoms of PPD include hallmarks of major depression, including, but not limited to, sadness, depressed mood, loss of interest, change in appetite, insomnia, sleeping too much, fatigue, difficulty thinking/concentrating, excessive crying, fear of harming the baby/oneself, and/or thoughts of death or suicide.

More news about: Lipocine Inc.


Feb 17, 2026, 14:39 ET Unlikely Collaborators Hosts Dr. Jade Wu: Why Sleep Changes How Everything Feels

also be livestreamed online. In-person attendees will receive a complimentary copy of Dr. Wu's book Hello Sleep: The Science and Art of Overcoming Insomnia Without Medications.Event Schedule6:00 p.m. — Doors open and reception7:00 p.m. — Program begins promptly8:00

More news about: Unlikely Collaborators


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.